HOME >> BIOLOGY >> NEWS
Specialized immune-system B cells play double-barreled role

lly altered mouse strains -- one that overproduced and one that was deficient in a protein called CD19 that is a key regulator of B-1a cell function and development. Thus, the two mouse strains enabled the researchers to explore the consequences of too many or too few B-1a cells. Also, the strain lacking CD19, and therefore B-1a cells, enabled the researchers to isolate sufficient numbers of pure B-1b cells for study.

The researchers studied how the immune systems of the two mouse strains reacted to infection with Streptococcus pneumoniae, the bacterium that causes pneumonia. They found that the mice lacking B-1a cells were susceptible to infection, showing they lacked the natural antibodies of the innate immune system. Yet, these mice could be protected by immunization, which activated their adaptive long-term immune system.

By contrast, the mice with overproduction of CD19 and thus overproduction of B-1a cells did not achieve adaptive immunity as a result of vaccination.

Thus, the researchers concluded that the B-1a cells regulate the innate immune response and the B-1b cells regulate the adaptive, long-term immune response.

Said Haas, "This reciprocal contribution of these two subtypes of B-1 cells to innate and acquired immunity was surprising to us. No one knew much about what these subsets do.

Our results indicate that there is a tiered response system in which one kind of B-1 cell consistently provides a low level of protection, while the other specifically responds to an infection to help eliminate it."

According to Haas and Tedder, the findings offer potential insights into the mechanism of vaccine action. For example, the new insights into the roles of the two B-1 cell subtypes could help explain why the immune-triggering molecules called antigens from the pneumococcus bacteria do not elicit a strong adaptive immune response in infants, people with compromised immune systems and the elderly. Such people may
'"/>

Contact: Dennis Meredith
dennis.meredith@duke.edu
919-681-8054
Duke University Medical Center
26-Jul-2005


Page: 1 2 3

Related biology news :

1. Specialized, bone-crushing wolves of Alaska disappeared long ago
2. New study may show how to forestall a fatal, virus-caused immune-system meltdown
3. Researchers in Montral and the US create model of key immune-system component
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. IRCM scientist demonstrates basic active mechanism of immune-system cells
6. Newly created cancer stem cells could aid breast cancer research
7. ESF EURYI award winner aims to stop cancer cells reading their own DNA
8. OHSU turns mouse into factory for human liver cells
9. UCLA scientists produce functioning neurons from human embryonic stem cells
10. UCF research links proteins, stem cells and potential Alzheimers treatment
11. Teamwork between 2 key proteins necessary for normal development and regulation of red blood cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/22/2016)... WASHINGTON , June 22, 2016 On ... highly-anticipated call to industry to share solutions for the ... by U.S. Customs and Border Protection (CBP), explains that ... nationals are departing the United States ... criminals, and to defeat imposters. Logo - ...
(Date:6/9/2016)... control systems is proud to announce the introduction of fingerprint attendance control software, allowing ... are actually signing in, and to even control the opening of doors. ... ... ... Photo - http://photos.prnewswire.com/prnh/20160609/377487 ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight Medical ... to the healthcare market. The company's primary focus is on new product introductions, ... strategies that are necessary to help companies efficiently bring their products to market. ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology:
Cached News: